Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

RAD9A Antikörper (pSer1129)

Der Kaninchen Polyklonal anti-RAD9A Antikörper wird verwendet zum Nachweis von RAD9A in Proben von Saccharomyces cerevisiae. Er wurde validiert für WB und EIA.
Produktnummer ABIN117923
1.129,23 €
Zzgl. Versandkosten 20,00 € und MwSt
0.1 mg
Lieferung nach: Deutschland
Lieferung in 16 Werktagen

Kurzübersicht für RAD9A Antikörper (pSer1129) (ABIN117923)

Target

Alle RAD9A Antikörper anzeigen
RAD9A (RAD9 Homolog A (S. Pombe) (RAD9A))

Reaktivität

  • 130
  • 52
  • 27
  • 8
  • 5
  • 2
  • 2
  • 1
  • 1
Saccharomyces cerevisiae

Wirt

  • 144
  • 12
  • 1
Kaninchen

Klonalität

  • 145
  • 12
Polyklonal

Konjugat

  • 78
  • 14
  • 9
  • 9
  • 4
  • 4
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser RAD9A Antikörper ist unkonjugiert

Applikation

  • 127
  • 68
  • 43
  • 41
  • 40
  • 29
  • 12
  • 10
  • 9
  • 7
  • 6
  • 5
  • 3
  • 2
  • 1
  • 1
Western Blotting (WB), Enzyme Immunoassay (EIA)
  • Bindungsspezifität

    • 20
    • 15
    • 15
    • 9
    • 8
    • 6
    • 6
    • 6
    • 6
    • 5
    • 5
    • 5
    • 4
    • 3
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    AA 1125-1139, pSer1129

    Aufreinigung

    Immunoaffinity chromatography.

    Immunogen

    This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to aa 1125-1139 of 1309 of yeast Rad9 protein conjugated to KLH.
  • Applikationshinweise

    This pan reactive polyclonal antibody was tested by Immunoblotting and ELISA. Data fromboth Immunoblotting and ELISA indicate the antibody is pan reactive with both thephosphorylated and non-phosphorylated forms of the peptide and protein. Immunoblotting detects yeast Rad9 protein. No reactivity is expected against human and mouse homologs. Reactivity to Rad9 fromothers sources is unknown. Although not tested, this antibody is likely functional byImmunohistochemistry and Immunoprecipitation. Recommended Dilution(s): This product has been assayed against 0.1 g of immunizingpeptide (S1129) in a standard capture ELISA using TMB (3,3',5,5'-Tetramethylbenizidine) asa substrate for 30 minutes at room temperature. A working dilution of 1: 5,000 is suggestedfor this product. Reactivity was detected against both the phosphorylated andnon-phosphorylated form (S1129 and pS1129) of the immunizing peptide. This antibodyappears to be pan reactive for both forms of the protein. Dilute the antibody 1: 100 to 1: 500for immunoblotting.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Konzentration

    0.74 mg/mL (by UV absorbance at 280 nm)

    Buffer

    0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 with 0.01 % (w/v) Sodium Azide as preservative.

    Konservierungsmittel

    Sodium azide

    Vorsichtsmaßnahmen

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Handhabung

    Dilute only prior to immediate use. Avoid cycles of freezing and thawing.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store vial at -20 °C or below prior to opening. Aliquot contents and freeze at -20 °C or below.
  • Target

    RAD9A (RAD9 Homolog A (S. Pombe) (RAD9A))

    Andere Bezeichnung

    RAD9A

    Hintergrund

    Rad9 is required for the MEC1/TEL1-dependent activation of Saccharomyces cerevisiae DNA damage checkpoint pathways mediated by Rad53 and Chk1. DNA damage induces Rad9 phosphorylation, and Rad53 specifically associates with phosphorylated Rad9. Cells have evolved multiple strategies for tolerating genomic damage. The most important of these are numerous repair systems that remove or bypass potentially mutagenic DNA lesions. Another cellular strategy is to delay cell-cycle transitions at multiple points. The genetic control of these delays, termed 'checkpoints', was first established in budding yeast where it was shown that the RAD9 gene functions in G2/M arrest after irradiation with X-rays. Subsequently, it has become clear that Rad9 also functions at the G1/S, intra-S and mid-anaphase checkpoints. Defects in checkpoint regulation can lead to genome instability and, in higher eukaryotes, neoplastic transformation. Rad9 also controls the transcriptional induction of a DNA damage regulon (DDR). Rad9 may also have a pro-apoptotic function. This is suggested in that Rad9 from Schizosaccharomyces pombe (SpRad9) contains a group of amino acids with similarity to the Bcl-2 homology 3 death domain, which is required for SpRad9 interaction with human Bcl-2 and apoptosis induction in human cells. Overexpression of Bcl-2 in S. pombe inhibits cell growth independently of rad9, but enhances resistance of rad9-null cells to methyl methanesulfonate, ultraviolet and ionizing radiation. Rad9 conveys the checkpoint signal by activating Rad53p and Chk1p, is hyperphosphorylated by Mec1p and Tel1p, and is a potential Cdc28p substrate. Mature yeast Rad9 is reported to have an apparent molecular weight of ~148 kDa. The human homolog is reported at 48.5 kDa.Synonyms: Cell cycle checkpoint control protein RAD9A, DNA repair exonuclease rad9 homolog A, EC=3.1.11.2, RAD-9A

    NCBI Accession

    NP_004575

    UniProt

    Q99638

    Pathways

    Positive Regulation of Response to DNA Damage Stimulus
Sie sind hier:
Chat with us!